PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tricore Reference Laboratory, Albuquerque, New Mexico, USA Steve.Young@Tricore.org charles_k_cooper@bd.com.\', \'Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.\', \'Becton, Dickinson and Company, BD Life Sciences-Integrated Diagnostic Solutions, Sparks, Maryland, USA.\', \'Tricore Reference Laboratory, Albuquerque, New Mexico, USA.\', \'Becton, Dickinson and Company, BD Life Sciences-Integrated Diagnostic Solutions, San Diego, California, USA.\', \'STAT Research, Vandalia, Ohio, USA.\', \'Comprehensive Clinical Research, LLC, West Palm Beach, Florida, USA.\', \'Becton, Dickinson and Company, BD Life Sciences-Integrated Diagnostic Solutions, Sparks, Maryland, USA Steve.Young@Tricore.org charles_k_cooper@bd.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e02338-2010.1128/JCM.02338-20
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 33023911
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all